Acrivon Therapeutics (ACRV) Income Statement: Revenue & Earnings

Acrivon Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Acrivon Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.13	0.54	0.00	0.00
Cost of Revenue	1.01	0.00	0.00	0.00	0.00
Gross Profit	-1.01	0.13	0.54	0.00	0.00
Operating Expenses
Research & Development	63.99	46.02	23.95	13.72	1.87
Selling, General & Administrative	25.21	21.08	8.71	2.47	1.30
Operating Expenses	89.20	67.10	32.66	16.18	3.17
Operating Income	-89.20	-67.10	-32.66	-16.18	-3.17
Other Income/Expense
Interest Income	9.20	7.04	0.00	0.00	0.03
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-0.56	0.32	0.79	-0.06	-0.07
Income
Income Before Tax	-80.56	-60.39	-31.17	-16.24	-5.31
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-80.56	-60.39	-31.17	-16.24	-5.31
Net Income - Continuous Operations	-80.56	-60.39	-31.17	-16.24	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-88.19	-59.89	-32.29	-16.15	-3.16
EBIT	-89.20	-60.39	-32.66	-16.18	-3.17
Depreciation & Amortization	1.01	0.50	0.36	0.04	0.01
Earnings Per Share
Basic EPS	-2.00	-3.00	-8.00	-9.00	-4.00
Diluted EPS	-2.00	-3.00	-8.00	-9.00	-4.00
Basic Shares Outstanding	33.79	22.08	4.12	1.74	1.43
Diluted Shares Outstanding	33.79	22.08	4.12	1.74	1.43